Overview
Jay Balagtas is a Hematologist and an Oncologist in Palo Alto, California. Dr. Balagtas is highly rated in 30 conditions, according to our data. His top areas of expertise are Hepatoblastoma, Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Ewing Sarcoma, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 40 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
Locations
725 Welch Rd, Palo Alto, CA 94304
1000 Welch Rd Ste 300, Palo Alto, CA 94304
Additional Areas of Focus
Dr. Balagtas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
40 Clinical Trials
UCSF Benioff Children's Hospital Oakland
Elliott Vichinsky is a Hematologist and an Oncologist in Oakland, California. Dr. Vichinsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
UCSF Benioff Children's Hospital Oakland
Ashutosh Lal is a Hematologist and an Oncologist in Oakland, California. Dr. Lal is highly rated in 12 conditions, according to our data. His top areas of expertise are Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
UCSF Benioff Children's Hospital Oakland
Mark Walters is a Hematologist and an Oncologist in Oakland, California. Dr. Walters is highly rated in 10 conditions, according to our data. His top areas of expertise are Hemoglobinopathy, Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Jay Balagtas
How do I make an appointment with Dr. Jay Balagtas?
You can book an appointment with Dr. Jay Balagtas by calling their office at 650-497-8953. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jay Balagtas a top-rated expert for Hepatoblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jay Balagtas is classified as an Distinguished expert for Hepatoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jay Balagtas specialize in?
While Dr. Jay Balagtas is a Hematology, they have specific expertise in Hepatoblastoma, Acute Lymphoblastic Leukemia (ALL), and Neuroblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Jay Balagtas participate in research or clinical trials?
Yes. Dr. Jay Balagtas has published 1 articles and abstracts on conditions like Hepatoblastoma. You can view a list of Dr. Jay Balagtas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jay Balagtas accept my insurance?
Dr. Jay Balagtas accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 650-497-8953 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Balagtas isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Ewing SarcomaDr. Balagtas isDistinguished. Learn about Ewing Sarcoma.
- HepatoblastomaDr. Balagtas isDistinguished. Learn about Hepatoblastoma.
- NeuroblastomaDr. Balagtas isDistinguished. Learn about Neuroblastoma.
- Advanced
- Acquired Amegakaryocytic Thrombocytopenia
- Adult Soft Tissue SarcomaDr. Balagtas isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-Pancytopenia SyndromeDr. Balagtas isAdvanced. Learn about Ataxia-Pancytopenia Syndrome.
- Cantu SyndromeDr. Balagtas isAdvanced. Learn about Cantu Syndrome.
- Classical Hodgkin LymphomaDr. Balagtas isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Congenital Aplastic AnemiaDr. Balagtas isAdvanced. Learn about Congenital Aplastic Anemia.
- Experienced
- Aase SyndromeDr. Balagtas isExperienced. Learn about Aase Syndrome.
- Acquired AgranulocytosisDr. Balagtas isExperienced. Learn about Acquired Agranulocytosis.
- Aplastic AnemiaDr. Balagtas isExperienced. Learn about Aplastic Anemia.
- Beta ThalassemiaDr. Balagtas isExperienced. Learn about Beta Thalassemia.
- Bone Marrow AspirationDr. Balagtas isExperienced. Learn about Bone Marrow Aspiration.
- Brain Stem CancerDr. Balagtas isExperienced. Learn about Brain Stem Cancer.